Pyelonephritis diagnostic study of choice

Jump to navigation Jump to search

Urinary Tract Infections Main Page

Pyelonephritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pyelonephritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocaridogram

X Ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pyelonephritis diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pyelonephritis diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pyelonephritis diagnostic study of choice

CDC on Pyelonephritis diagnostic study of choice

Pyelonephritis diagnostic study of choice in the news

Blogs on Pyelonephritis diagnostic study of choice

Directions to Hospitals Treating Pyelonephritis

Risk calculators and risk factors for Pyelonephritis diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Diagnostic Study of Choice

Study of choice

  • Urinalysis and urine culture with susceptibility testing might confirm the diagnosis of pyelonephritis.[1][2][3]
  • Pyelonephritis must be suspected if the patient has urinary symptoms including dysuria, urgency, frequency, or suprapubic pain, along with fever, chills, flank pain, pelvic or perineal pain.
  • Imaging would not be necessary for patients with pyelonephritis, unless in patients with severe and refractory illness or suspected urinary tract obstruction.

The comparison of various diagnostic studies for pyelonephritis

Test Sensitivity Specificity
Urinalysis WBC > 5 WBCs/HPF 72-95% 48-82%
> 10 WBCs/HPF 58-82% 65-86%
RBC + 44% 88%
Leukocyte esterase test + 74-96% 94-98%
Nitrite test + 35-85% 92-100%
Combination leukocyte esterase and nitrite tests Either test + 75-84% 82-98%
Gram stain of uncentrifuged urine > 1 bacterium per HPF 93% 95%
Urine culture + 90%
Blood culture + 20%

References

  1. Ramakrishnan K, Scheid DC (2005). "Diagnosis and management of acute pyelonephritis in adults". Am Fam Physician. 71 (5): 933–42. PMID 15768623.
  2. Hoverman IV, Gentry LO, Jones DW, Guerriero WG (1980). "Intrarenal abscess. Report of 14 cases". Arch Intern Med. 140 (7): 914–6. PMID 6992728.
  3. Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG; et al. (2011). "International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases". Clin Infect Dis. 52 (5): e103–20. doi:10.1093/cid/ciq257. PMID 21292654.

Template:WH Template:WS